TORONTO, Sept. 12, 2024
In this free webinar, gain insights into the transformative impact of long-term cardiovascular monitoring technologies on clinical trials. Attendees will learn about the definition of long-term cardiovascular data and the need for long-term cardiovascular data. The featured speakers will discuss how long-term cardiovascular data can support a cardiac safety portfolio. The speakers will also share what new technologies are available for the collection of long-term cardiovascular data.
Advertisement
TORONTO, Sept. 12, 2024 /PRNewswire-PRWeb/ -- Cardiac safety testing is an important part of the approval of new chemical entities (NCEs). For more than 20 years, cardiac safety testing has been focused on QT interval assessment as a surrogate for the potential of an NCE to cause "Torsade de Pointes" — a specific life-threatening ventricular arrhythmia that is potentially associated with QT interval prolongation. However, these analyses have been conducted using limited, short-term data in a resting state.
Advertisement
Newer technologies allow for the collection of long-term data in a more dynamic, real-world setting. Cardiac monitoring has benefited from the advent of multiple-day recordings, allowing for ECG collection in dynamic settings.
Regulatory agencies are becoming more aware of the need to gather long-term cardiovascular data and the new technologies available to facilitate collection. As long-term cardiovascular technology advances, it will become increasingly easier to utilise it for the collection of continuous cardiovascular safety data in clinical trials.
In this webinar, the expert speaker will discuss:
Register for this webinar today to gain insights into the transformative impact of long-term cardiovascular monitoring technologies on clinical trials.
Join experts from ICON, Dr. Polina Voloshko, MD, Senior Medical Director and Head of Medical & Scientific Affairs, Cardiovascular & Cardiac Safety Solutions; and Timothy Callahan, PhD, Medical & Scientific Director, Cardiac Safety Solutions, for the live webinar on Tuesday, October 1, 2024, at 10am EDT (4pm CEST/EU-Central).
For more information, or to register for this event, visit Continuous long term cardiovascular monitoring in clinical trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/continuous-long-term-cardiovascular-monitoring-in-clinical-trials-upcoming-webinar-hosted-by-xtalks-302246834.html
SOURCE Xtalks
